Hugo G. Snippert
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.
Journal: British journal of cancer
Published: June 13, 2025
Emergence of oncofetal plasticity is ubiquitous in early colorectal cancers.
Journal: Nature
Published: March 07, 2025
Efficacy and safety in early-phase clinical trials for refractory colorectal cancer: A meta-analysis.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 05, 2024
Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors.
Journal: Molecular cancer therapeutics
Published: March 27, 2024
Mechanosensitive calcium channels and integrins coordinate the reprogramming of colorectal cancer cells into a fetal-like state.
Journal: Cell reports
Published: June 11, 2023
Chromosomal copy number heterogeneity predicts survival rates across cancers.
Journal: Nature communications
Published: February 10, 2021
Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses.
Journal: Cell reports
Published: December 18, 2019
Colorectal Cancer Modeling with Organoids: Discriminating between Oncogenic RAS and BRAF Variants.
Journal: Trends in cancer
Published: September 02, 2019
Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity.
Journal: Molecular cancer research : MCR
Published: May 17, 2019
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity.
Journal: Nature medicine
Published: November 28, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026